We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
NIKE's High P/E Valuation: Can Fundamentals Justify the Premium?
Read MoreHide Full Article
Key Takeaways
NIKE's 20.12X forward P/E exceeds the industry average of 17.3X despite recent stock weakness.
FY27 revenues are expected to fall in the high single digits, while EBIT is projected to decline faster.
NIKE faces weakness in Sportswear, Jordan Brand and Greater China as turnaround benefits remain delayed.
NIKE Inc. (NKE - Free Report) stock has been volatile in recent months, reflecting weakening demand, margin pressure and ongoing business-reset actions. However, its current forward 12-month price-to-earnings (P/E) ratio of 20.12X raises valuation concerns. This multiple exceeds the Zacks Shoes and Retail Apparel industry average of 17.3X, making NIKE’s stock appear relatively expensive.
Adding to investor caution, the company’s elevated price-to-sales (P/S) ratio affects enthusiasm. The Beaverton, OR-based athletic giant trades at a forward 12-month P/S of 1.11X, above the industry’s 1.04X. Together with its Value Score of D, this suggests that NIKE may not present a compelling value opportunity at current levels despite its strong fundamentals and brand leadership.
Image Source: Zacks Investment Research
NIKE’s Premium Valuation Surpasses Peers
At 20.12X P/E, the Swoosh brand owner is trading at a much higher valuation than its competitors. Its peers, such as adidas AG (ADDYY - Free Report) , Steven Madden (SHOO - Free Report) and Wolverine World Wide (WWW - Free Report) , are delivering solid growth and trade at more reasonable multiples. adidas, Steven Madden and Wolverine have forward 12-month P/E ratios of 12.57X, 17.84X and 10.52X — all lower than that of NIKE. At such levels, NKE’s valuation seems out of step with its growth trajectory, especially given the recent decrease in its stock price.
NIKE’s elevated valuation underscores investors’ high growth expectations. However, compared with key competitors, the company appears increasingly vulnerable as market participants turn cautious toward overpriced Consumer Discretionary stocks. NKE’s ability to consistently deliver on or exceed these expectations will be critical to sustaining its premium valuation.
NIKE shares have lost 22.9% in the past three months compared with a 19.7% decline in the broader industry. The stock has also underperformed the Consumer Discretionary sector’s 5.7% decline and the S&P 500’s 2% growth in the same period.
NIKE’s performance has been relatively dismal compared with its peers. Shares of Wolverine World Wide and Steven Madden have outperformed NKE in the past three months, recording 10.4% and 14.6% growth, respectively. Meanwhile, shares of adidas have underperformed NKE with a 24.9% decline.
NKE’s 3-Month Stock Performance
Image Source: Zacks Investment Research
At the current price of $33.96, the NKE stock trades close to its 52-week low of $31.94 reached on Oct. 2, 2026. The recent fall to the 52-week low was led by the company’s dismal first-quarter fiscal 2027 results on Oct. 1. The current stock price is 53.1% below its 52-week high mark of $72.39. NKE trades below its 50 and 200-day moving averages, indicating a bearish sentiment.
NIKE’s recent share-price pressure appears fundamentally tied to concerns that its turnaround will take longer and involve greater near-term earnings pain. First-quarter fiscal 2027 revenues declined 4% on a reported basis and 5% on a currency-neutral basis, underscoring persistent weakness across several key businesses.
NIKE Sportswear, Jordan Brand and Greater China remain the primary drags, offsetting solid momentum in the Performance portfolio. Sportswear declined in the low double digits, hurt by a nearly 50% reduction in Dunk revenues, weaker-than-expected sell-through of aged footwear and softer lifestyle traffic. Management also acknowledged broader marketplace pressure and a lack of energy in the lifestyle category.
Jordan Brand is another near-term headwind. Revenues fell in the mid-teens as NIKE deliberately reduces the volume and frequency of retro launches to restore scarcity and strengthen brand positioning. While strategically necessary, these actions are expected to weigh on sales, particularly in North America.
Greater China remains even more challenging, with revenues down 26% as NIKE restructures digital distribution, removes discount-heavy channels and works to improve inventory health. Management expects revenues and profitability in China to remain pressured for multiple seasons.
The outlook further explains investor caution. NIKE expects fiscal 2027 revenues to decline in the high-single-digit range, with EBIT falling faster than sales due to gross-margin pressure, fixed-cost deleverage and higher input costs. Although the Pace restructuring is expected to generate $2.5 billion in savings, most benefits are not expected until fiscal 2029-2030, reinforcing a prolonged “pain before gain” narrative.
NIKE’s Estimate Revision Trend
The Zacks Consensus Estimate for NIKE’s fiscal 2027 and 2028 earnings per share (EPS) have moved south, with estimates declining 3% and 2.3%, respectively, in the past seven days.
Image Source: Zacks Investment Research
For fiscal 2027, the Zacks Consensus Estimate for NKE’s revenues implies a 7% year-over-year decline, while the same for EPS suggests 1.3% growth. The consensus mark for fiscal 2028 revenues and EPS indicates 9.5% and 32.6% year-over-year growth, respectively.
Is NIKE Still Worth a Shot?
NIKE’s first-quarter fiscal 2027 performance underscores the near-term pains surrounding its turnaround. Persistent weakness in Sportswear, Jordan Brand and Greater China, coupled with expectations for a high-single-digit revenue decline and greater pressure on EBIT, suggests that a meaningful recovery may take time. Against this backdrop, NIKE’s premium valuation looks difficult to justify, particularly as the stock continues to decline and trades near its 52-week low.
The negative estimate revision trend adds another concern. Although management’s restructuring efforts and Performance portfolio strength could support longer-term improvement, the current outlook remains subdued and execution risks are elevated.
Given the combination of a premium valuation, deteriorating share-price performance, downward earnings estimate revisions and a weak near-term operating outlook, investors may be better off staying on the sidelines. NIKE currently carries a Zacks Rank #5 (Strong Sell), and it appears prudent to avoid the stock until clearer signs of revenue stabilization, margin recovery and improving earnings momentum emerge.
View the Zacks #1 Rank List
Image: Bigstock
NIKE's High P/E Valuation: Can Fundamentals Justify the Premium?
Key Takeaways
NIKE Inc. (NKE - Free Report) stock has been volatile in recent months, reflecting weakening demand, margin pressure and ongoing business-reset actions. However, its current forward 12-month price-to-earnings (P/E) ratio of 20.12X raises valuation concerns. This multiple exceeds the Zacks Shoes and Retail Apparel industry average of 17.3X, making NIKE’s stock appear relatively expensive.
Adding to investor caution, the company’s elevated price-to-sales (P/S) ratio affects enthusiasm. The Beaverton, OR-based athletic giant trades at a forward 12-month P/S of 1.11X, above the industry’s 1.04X. Together with its Value Score of D, this suggests that NIKE may not present a compelling value opportunity at current levels despite its strong fundamentals and brand leadership.
Image Source: Zacks Investment Research
NIKE’s Premium Valuation Surpasses Peers
At 20.12X P/E, the Swoosh brand owner is trading at a much higher valuation than its competitors. Its peers, such as adidas AG (ADDYY - Free Report) , Steven Madden (SHOO - Free Report) and Wolverine World Wide (WWW - Free Report) , are delivering solid growth and trade at more reasonable multiples. adidas, Steven Madden and Wolverine have forward 12-month P/E ratios of 12.57X, 17.84X and 10.52X — all lower than that of NIKE. At such levels, NKE’s valuation seems out of step with its growth trajectory, especially given the recent decrease in its stock price.
NIKE’s elevated valuation underscores investors’ high growth expectations. However, compared with key competitors, the company appears increasingly vulnerable as market participants turn cautious toward overpriced Consumer Discretionary stocks. NKE’s ability to consistently deliver on or exceed these expectations will be critical to sustaining its premium valuation.
NIKE shares have lost 22.9% in the past three months compared with a 19.7% decline in the broader industry. The stock has also underperformed the Consumer Discretionary sector’s 5.7% decline and the S&P 500’s 2% growth in the same period.
NIKE’s performance has been relatively dismal compared with its peers. Shares of Wolverine World Wide and Steven Madden have outperformed NKE in the past three months, recording 10.4% and 14.6% growth, respectively. Meanwhile, shares of adidas have underperformed NKE with a 24.9% decline.
NKE’s 3-Month Stock Performance
Image Source: Zacks Investment Research
At the current price of $33.96, the NKE stock trades close to its 52-week low of $31.94 reached on Oct. 2, 2026. The recent fall to the 52-week low was led by the company’s dismal first-quarter fiscal 2027 results on Oct. 1. The current stock price is 53.1% below its 52-week high mark of $72.39. NKE trades below its 50 and 200-day moving averages, indicating a bearish sentiment.
NIKE Stock Trades Below 50 & 200-Day Moving Averages
Image Source: Zacks Investment Research
What’s Hurting NIKE’s Stock Performance
NIKE’s recent share-price pressure appears fundamentally tied to concerns that its turnaround will take longer and involve greater near-term earnings pain. First-quarter fiscal 2027 revenues declined 4% on a reported basis and 5% on a currency-neutral basis, underscoring persistent weakness across several key businesses.
NIKE Sportswear, Jordan Brand and Greater China remain the primary drags, offsetting solid momentum in the Performance portfolio. Sportswear declined in the low double digits, hurt by a nearly 50% reduction in Dunk revenues, weaker-than-expected sell-through of aged footwear and softer lifestyle traffic. Management also acknowledged broader marketplace pressure and a lack of energy in the lifestyle category.
Jordan Brand is another near-term headwind. Revenues fell in the mid-teens as NIKE deliberately reduces the volume and frequency of retro launches to restore scarcity and strengthen brand positioning. While strategically necessary, these actions are expected to weigh on sales, particularly in North America.
Greater China remains even more challenging, with revenues down 26% as NIKE restructures digital distribution, removes discount-heavy channels and works to improve inventory health. Management expects revenues and profitability in China to remain pressured for multiple seasons.
The outlook further explains investor caution. NIKE expects fiscal 2027 revenues to decline in the high-single-digit range, with EBIT falling faster than sales due to gross-margin pressure, fixed-cost deleverage and higher input costs. Although the Pace restructuring is expected to generate $2.5 billion in savings, most benefits are not expected until fiscal 2029-2030, reinforcing a prolonged “pain before gain” narrative.
NIKE’s Estimate Revision Trend
The Zacks Consensus Estimate for NIKE’s fiscal 2027 and 2028 earnings per share (EPS) have moved south, with estimates declining 3% and 2.3%, respectively, in the past seven days.
Image Source: Zacks Investment Research
For fiscal 2027, the Zacks Consensus Estimate for NKE’s revenues implies a 7% year-over-year decline, while the same for EPS suggests 1.3% growth. The consensus mark for fiscal 2028 revenues and EPS indicates 9.5% and 32.6% year-over-year growth, respectively.
Is NIKE Still Worth a Shot?
NIKE’s first-quarter fiscal 2027 performance underscores the near-term pains surrounding its turnaround. Persistent weakness in Sportswear, Jordan Brand and Greater China, coupled with expectations for a high-single-digit revenue decline and greater pressure on EBIT, suggests that a meaningful recovery may take time. Against this backdrop, NIKE’s premium valuation looks difficult to justify, particularly as the stock continues to decline and trades near its 52-week low.
The negative estimate revision trend adds another concern. Although management’s restructuring efforts and Performance portfolio strength could support longer-term improvement, the current outlook remains subdued and execution risks are elevated.
Given the combination of a premium valuation, deteriorating share-price performance, downward earnings estimate revisions and a weak near-term operating outlook, investors may be better off staying on the sidelines. NIKE currently carries a Zacks Rank #5 (Strong Sell), and it appears prudent to avoid the stock until clearer signs of revenue stabilization, margin recovery and improving earnings momentum emerge.
You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.